Join the WWCME webinar, “Ultrasound Screening with an Update on AI Tools,” presented by Dr. Georgia Spear. https://t.co/CNnVsTJn1k
This activity is supported by an unrestricted educationa...
The recent FDA updates to the mammography guidelines now require all facilities to notify patients and their health care providers about their breast density.
Click here to learn more about supplement screening: https://t.co/pLKUk2ETN2...
Great op-ed! Thank you to @kaufield for your advocacy on behalf of the women of New Brunswick! @premierbhiggs@BruceFitchMLA please give the women of NB a chance to find breast cancer early. The same chance that women in other provinces have. @nb_docs
Register now to hear from thought leaders Mohamed Lareef, MD, FACS, Dian Lack, RN, Lisa R. Stempel, MD, Fiona Gilbert, FRCR, FRCPG, FRCPE, FRSE, FMedSci., JoAnn Puskin, and Yossi Abu about the latest advancements in medical imaging. https://t.co/n0uHAovxPz
Register now to hear from thought leaders Timothy Deyer, MD, Philip Blaustein, MD, Charles Martin III, MD, Ben Newton PhD, Doug Whisler, and Alexandra Schulz about the latest advancements in medical imaging. https://t.co/c32nUPNpjn
It's that time again and we have so much to share with you. Schedule some time to see the AI features of Invenia 2.0 ABUS. Help us help you find invasive breast cancer at a low stage.
Invenia™ ABUS is the first FDA approved #ultrasound supplemental screening device that is specifically designed for detecting cancer in #densebreasts to move breast care from reactive to proactive. https://t.co/xwbNPyO9v6
Invenia™ ABUS is the first FDA approved #ultrasound supplemental screening device that is specifically designed for detecting cancer in #densebreasts to move breast care from reactive to proactive. https://t.co/6GP0XUSKNt
October is Breast Cancer Awareness Month! Walk in the shoe of a breast care patient in a multimodality breast imaging center! #breastcancer#mammography#ultrasound#ABUS https://t.co/OmTDo8MFXI
Over 40% of women have dense breasts, and more than 250,000 women living in the United States today were diagnosed with breast cancer under age 40. Leah was 37 with dense breasts, when her cancer was detected on ultrasound. https://t.co/fTjVmnQf42
💡 Did you know that by adding ABUS to mammography screening can increase sensitivity by 57% when detecting breast cancer for women with dense breasts.
Explore how our solutions do just this: https://t.co/XPnR3w7Cnz https://t.co/uhSF9dHCwr
💡 Did you know that by adding ABUS to mammography screening can increase sensitivity by 57% when detecting breast cancer for women with dense breasts.
Explore how our solutions do just this: https://t.co/XPnR3vPt9r https://t.co/URa0wfdW3p
70% of ALL breast cancers occur in women with dense breasts. Join us for an educational webinar with the opportunity to earn 1.25 CEUs and learn more about the need for adjunct screening for women with dense breasts.
https://t.co/c5TfpPZFOE
Personalized Breast Care - Hear Gulsen's Story and how this clinical approach found her cancer at a very early stage to be a live changer and live saver #ultrasound#ABUS https://t.co/APEvodKoxQ
The new Mobile Invenia ABUS 2.0 for women with dense breasts to deliver personalized Breast Care. Everywhere.
#ultrasound#mammography#breastcancer#ABUS https://t.co/NnUVvwr8Tl